title: Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction.
abstract: The effects of three tyrosine kinase inhibitors: genistein, quercetin and psi-tectorigenin, were investigated on contractions evoked in de-endothelised rat aortic rings, either by phenylephrine or 70 mM K+. A dose-dependent inhibition of both contractions by all three compounds was observed, the phenylephrine-mediated contractions being more sensitive to genistein. No differences between genistein or quercetin effects in pre-treatment or post-treatment protocols were found. Ca2+ store refilling, expressed in terms of phenylephrine-induced tension in Ca(2+)-free medium, was dose-dependently blocked by quercetin and genistein. Sodium orthovanadate, an inhibitor of tyrosine phosphatase, contracted the rat aortic rings with an IC50 of 0.66 microM. Its presence during the refilling period after exposure to Ca(2+)-free medium completely prevented the subsequent response to phenylephrine. One can conclude that the use of the above-mentioned protein tyrosine kinase inhibitors in the rat aorta blocks a step involved in Ca2+ entry and Ca2+ store refilling. A definite conclusion regarding the vanadate effects is not possible due to the fact that this compound also affects Ca2+ ATP-ases.
authors.affiliation: Department of Physiology, University of Medicine and Pharmacy Gr. T. Popa, Romania.
authors.forename: C M
authors.initials: CM
authors.lastname: Filipeanu
authors.forename: E
authors.initials: E
authors.lastname: Brailoiu
authors.forename: G
authors.initials: G
authors.lastname: Huhurez
authors.forename: S
authors.initials: S
authors.lastname: Slatineanu
authors.forename: O
authors.initials: O
authors.lastname: Baltatu
authors.forename: D D
authors.initials: DD
authors.lastname: Branisteanu
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D003470:Culture Media; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D019833:Genistein; D066298:In Vitro Techniques; D007529:Isoflavones / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology* / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011794:Quercetin / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014638:Vanadates / Q000494:pharmacology
chemical_list: D003470:Culture Media; D004791:Enzyme Inhibitors; D007529:Isoflavones; D014638:Vanadates; C055439:psi-tectorigenin; D011794:Quercetin; D019833:Genistein; D011505:Protein-Tyrosine Kinases; D002118:Calcium